{"transactions":[{"id":1201996,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":81856,"kind":"person","name":"Nunes Anne","position":1,"cik":"0001982862","reported_name":"Nunes Anne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Operations Officer"}}],"security":"Restricted Stock Unit","published_at":"2025-03-18T21:16:55.000Z","date":"2025-03-17","kind":"exercise","planned":false,"acquired":false,"shares":3637,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Each RSU represents the contingent right to receive, at the Company's discretion, one share of the Company's common stock, or the cash equivalent of the closing price of one share of the Company's common stock, on each vest date. The RSUs vest in three equal annual installments beginning March 15, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Each RSU represents the contingent right to receive, at the Company's discretion, one share of the Company's common stock, or the cash equivalent of the closing price of one share of the Company's common stock, on each vest date. The RSUs vest in three equal annual installments beginning March 15, 2025."}],"balance_after":7275,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":3637},"source":{"system":"sec-edgar","filing":"0001171843-25-001534","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184325001534/ownership.xml","form_type":"4"}},{"id":1201995,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":81856,"kind":"person","name":"Nunes Anne","position":1,"cik":"0001982862","reported_name":"Nunes Anne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Operations Officer"}}],"security":"Restricted Stock Unit","published_at":"2025-03-18T21:16:55.000Z","date":"2025-03-14","kind":"grant","planned":false,"acquired":true,"shares":4650,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Each RSU represents the contingent right to receive, at the Company's discretion, one share of the Company's common stock, or the cash equivalent of the closing price of one share of the Company's common stock, on the vest date. The 4,650 RSUs represent the Target number of shares that may be earned in conjunction with certain market metrics prescribed under the terms of the performance-based phantom RSU award. The award shall cliff vest on the 3rd anniversary of the grant date, subject to the Compensation Committee's determination of achievement of the award prior to the vest date. The number of shares earned and subject to vest, as determined by the Compensation Committee, may be in a range from Threshold (50% of Target) to Maximum (200% of Target). No shares shall vest for achievement under Threshold."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Each RSU represents the contingent right to receive, at the Company's discretion, one share of the Company's common stock, or the cash equivalent of the closing price of one share of the Company's common stock, on the vest date. The 4,650 RSUs represent the Target number of shares that may be earned in conjunction with certain market metrics prescribed under the terms of the performance-based phantom RSU award. The award shall cliff vest on the 3rd anniversary of the grant date, subject to the Compensation Committee's determination of achievement of the award prior to the vest date. The number of shares earned and subject to vest, as determined by the Compensation Committee, may be in a range from Threshold (50% of Target) to Maximum (200% of Target). No shares shall vest for achievement under Threshold."}],"balance_after":4650,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":4650},"source":{"system":"sec-edgar","filing":"0001171843-25-001534","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184325001534/ownership.xml","form_type":"4"}},{"id":1201994,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":81856,"kind":"person","name":"Nunes Anne","position":1,"cik":"0001982862","reported_name":"Nunes Anne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Operations Officer"}}],"security":"Restricted Stock Unit","published_at":"2025-03-18T21:16:55.000Z","date":"2025-03-14","kind":"grant","planned":false,"acquired":true,"shares":20761,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Each RSU represents the contingent right to receive, at the Company's discretion, one share of the Company's common stock, or the cash equivalent of the closing price of one share of the Company's common stock, on each vest date. The RSUs vest in three equal annual installments beginning March 14, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Each RSU represents the contingent right to receive, at the Company's discretion, one share of the Company's common stock, or the cash equivalent of the closing price of one share of the Company's common stock, on each vest date. The RSUs vest in three equal annual installments beginning March 14, 2026."}],"balance_after":20761,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":20761},"source":{"system":"sec-edgar","filing":"0001171843-25-001534","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184325001534/ownership.xml","form_type":"4"}},{"id":1201993,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":81856,"kind":"person","name":"Nunes Anne","position":1,"cik":"0001982862","reported_name":"Nunes Anne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Operations Officer"}}],"security":"Common Stock","published_at":"2025-03-18T21:16:55.000Z","date":"2025-03-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":1068,"price":15.91,"value":16991.88,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Reflects an aggregate of 1,068 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on March 15, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects the closing price of ANIK common stock on March 14, 2025, the trading day prior to which the vesting of RSUs gave rise to tax withholding obligations."}],"balance_after":20654,"source":{"system":"sec-edgar","filing":"0001171843-25-001534","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184325001534/ownership.xml","form_type":"4"}},{"id":1201992,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":81856,"kind":"person","name":"Nunes Anne","position":1,"cik":"0001982862","reported_name":"Nunes Anne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Operations Officer"}}],"security":"Common Stock","published_at":"2025-03-18T21:16:55.000Z","date":"2025-03-17","kind":"exercise","planned":false,"acquired":true,"shares":3637,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the first vesting installment of RSUs granted on March 15, 2024, which the Company elected to settle in shares."}],"balance_after":21722,"source":{"system":"sec-edgar","filing":"0001171843-25-001534","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184325001534/ownership.xml","form_type":"4"}},{"id":1208414,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":81856,"kind":"person","name":"Nunes Anne","position":1,"cik":"0001982862","reported_name":"Nunes Anne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Operations Officer"}}],"security":"Restricted Stock Unit","published_at":"2025-03-13T21:19:35.000Z","date":"2025-03-11","kind":"exercise","planned":false,"acquired":false,"shares":2561,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning March 11, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning March 11, 2023."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":2561},"source":{"system":"sec-edgar","filing":"0001171843-25-001470","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184325001470/ownership.xml","form_type":"4"}},{"id":1208413,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":81856,"kind":"person","name":"Nunes Anne","position":1,"cik":"0001982862","reported_name":"Nunes Anne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Operations Officer"}}],"security":"Common Stock","published_at":"2025-03-13T21:19:35.000Z","date":"2025-03-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":752,"price":16.79,"value":12626.08,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Reflects an aggregate of 752 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on March 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects the closing price of ANIK common stock on March 11, 2025, the trading day to which the vesting of RSUs gave rise to tax withholding obligations."}],"balance_after":18085,"source":{"system":"sec-edgar","filing":"0001171843-25-001470","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184325001470/ownership.xml","form_type":"4"}},{"id":1208412,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":81856,"kind":"person","name":"Nunes Anne","position":1,"cik":"0001982862","reported_name":"Nunes Anne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Operations Officer"}}],"security":"Common Stock","published_at":"2025-03-13T21:19:35.000Z","date":"2025-03-11","kind":"exercise","planned":false,"acquired":true,"shares":2561,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the third and final vesting installment of RSUs granted on March 11, 2022."}],"balance_after":18837,"source":{"system":"sec-edgar","filing":"0001171843-25-001470","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184325001470/ownership.xml","form_type":"4"}},{"id":1213503,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":81856,"kind":"person","name":"Nunes Anne","position":1,"cik":"0001982862","reported_name":"Nunes Anne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Operations Officer"}}],"security":"Restricted Stock Unit","published_at":"2025-03-11T21:18:31.000Z","date":"2025-03-10","kind":"exercise","planned":false,"acquired":false,"shares":3296,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning March 9, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning March 9, 2024."}],"balance_after":3295,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":3296},"source":{"system":"sec-edgar","filing":"0001171843-25-001406","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184325001406/ownership.xml","form_type":"4"}},{"id":1213502,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":81856,"kind":"person","name":"Nunes Anne","position":1,"cik":"0001982862","reported_name":"Nunes Anne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Operations Officer"}}],"security":"Common Stock","published_at":"2025-03-11T21:18:31.000Z","date":"2025-03-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":959,"price":16.62,"value":15938.58,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Reflects an aggregate of 959 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on March 9, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Reflects the closing price of ANIK common stock on March 7, 2025, the trading day prior to which the vesting of RSUs gave rise to tax withholding obligations."}],"balance_after":16276,"source":{"system":"sec-edgar","filing":"0001171843-25-001406","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184325001406/ownership.xml","form_type":"4"}},{"id":1213501,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":81856,"kind":"person","name":"Nunes Anne","position":1,"cik":"0001982862","reported_name":"Nunes Anne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Operations Officer"}}],"security":"Common Stock","published_at":"2025-03-11T21:18:31.000Z","date":"2025-03-10","kind":"exercise","planned":false,"acquired":true,"shares":3296,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the second vesting installment of RSUs granted on March 9, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes the following shares acquired under the Anika Therapeutics, Inc. Employee Stock Purchase Plan: 460 shares purchased on November 14, 2024."}],"balance_after":17235,"source":{"system":"sec-edgar","filing":"0001171843-25-001406","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184325001406/ownership.xml","form_type":"4"}},{"id":1391071,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":81856,"kind":"person","name":"Nunes Anne","position":1,"cik":"0001982862","reported_name":"Nunes Anne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Operations Officer"}}],"security":"Restricted Stock Unit","published_at":"2024-10-04T20:06:58.000Z","date":"2024-10-01","kind":"exercise","planned":false,"acquired":false,"shares":2491,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning October 1, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning October 1, 2022."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":2491},"source":{"system":"sec-edgar","filing":"0001171843-24-005510","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184324005510/ownership.xml","form_type":"4"}},{"id":1391070,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":81856,"kind":"person","name":"Nunes Anne","position":1,"cik":"0001982862","reported_name":"Nunes Anne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Operations Officer"}}],"security":"Common Stock","published_at":"2024-10-04T20:06:58.000Z","date":"2024-10-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":732,"price":24.27,"value":17765.64,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Reflects an aggregate of 732 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on October 1, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Reflects the closing price of ANIK common stock on October 1, 2024, the trading day on which the vesting of RSUs gave rise to tax withholding obligations."}],"balance_after":13479,"source":{"system":"sec-edgar","filing":"0001171843-24-005510","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184324005510/ownership.xml","form_type":"4"}},{"id":1391069,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":81856,"kind":"person","name":"Nunes Anne","position":1,"cik":"0001982862","reported_name":"Nunes Anne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Operations Officer"}}],"security":"Common Stock","published_at":"2024-10-04T20:06:58.000Z","date":"2024-10-01","kind":"exercise","planned":false,"acquired":true,"shares":2491,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the third and final vesting installment of RSUs granted on October 1, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 634 shares acquired under the Anika Therapeutics, Inc. Employee Stock Purchase Plan on May 14, 2024."}],"balance_after":14211,"source":{"system":"sec-edgar","filing":"0001171843-24-005510","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184324005510/ownership.xml","form_type":"4"}},{"id":1570706,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":81856,"kind":"person","name":"Nunes Anne","position":1,"cik":"0001982862","reported_name":"Nunes Anne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Operations Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-03-19T21:17:11.000Z","date":"2024-03-15","kind":"grant","planned":false,"acquired":true,"shares":26442,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Represents a 10% premium above the closing price of Anika's common stock on the date of grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The premium priced stock options vest in three equal annual installments beginning on March 15, 2025."}],"balance_after":26442,"derivative":{"exercise_price":27.98,"expiration_date":"2034-03-11","underlying":"Common Stock","underlying_shares":26442},"source":{"system":"sec-edgar","filing":"0001171843-24-001459","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184324001459/ownership.xml","form_type":"4"}},{"id":1570705,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":81856,"kind":"person","name":"Nunes Anne","position":1,"cik":"0001982862","reported_name":"Nunes Anne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Operations Officer"}}],"security":"Restricted Stock Unit","published_at":"2024-03-19T21:17:11.000Z","date":"2024-03-15","kind":"grant","planned":false,"acquired":true,"shares":10912,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each RSU represents the contingent right to receive, at the Company's discretion, one share of the Company's common stock, or the cash equivalent of the closing price of one share of the Company's common stock, on each vest date. The RSUs vest in three equal annual installments beginning March 15, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each RSU represents the contingent right to receive, at the Company's discretion, one share of the Company's common stock, or the cash equivalent of the closing price of one share of the Company's common stock, on each vest date. The RSUs vest in three equal annual installments beginning March 15, 2025."}],"balance_after":10912,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":10912},"source":{"system":"sec-edgar","filing":"0001171843-24-001459","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184324001459/ownership.xml","form_type":"4"}},{"id":1582382,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":81856,"kind":"person","name":"Nunes Anne","position":1,"cik":"0001982862","reported_name":"Nunes Anne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Operations Officer"}}],"security":"Restricted Stock Unit","published_at":"2024-03-13T00:02:39.000Z","date":"2024-03-11","kind":"exercise","planned":false,"acquired":false,"shares":2561,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning March 11, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F10","text":"Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning March 11, 2023."}],"balance_after":2561,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":2561},"source":{"system":"sec-edgar","filing":"0001171843-24-001305","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184324001305/ownership.xml","form_type":"4"}},{"id":1582381,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":81856,"kind":"person","name":"Nunes Anne","position":1,"cik":"0001982862","reported_name":"Nunes Anne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Operations Officer"}}],"security":"Restricted Stock Unit","published_at":"2024-03-13T00:02:39.000Z","date":"2024-03-11","kind":"exercise","planned":false,"acquired":false,"shares":3295,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning March 9, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F9","text":"Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning March 9, 2024."}],"balance_after":6591,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":3295},"source":{"system":"sec-edgar","filing":"0001171843-24-001305","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184324001305/ownership.xml","form_type":"4"}},{"id":1582380,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":81856,"kind":"person","name":"Nunes Anne","position":1,"cik":"0001982862","reported_name":"Nunes Anne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Operations Officer"}}],"security":"Common Stock","published_at":"2024-03-13T00:02:39.000Z","date":"2024-03-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":752,"price":25.79,"value":19394.08,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F7","text":"Reflects an aggregate of 752 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on March 11, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"Reflects the closing price of ANIK common stock on March 11, 2024, the trading day on which the vesting of RSUs gave rise to tax withholding obligations."}],"balance_after":11086,"source":{"system":"sec-edgar","filing":"0001171843-24-001305","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184324001305/ownership.xml","form_type":"4"}},{"id":1582379,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":81856,"kind":"person","name":"Nunes Anne","position":1,"cik":"0001982862","reported_name":"Nunes Anne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Operations Officer"}}],"security":"Common Stock","published_at":"2024-03-13T00:02:39.000Z","date":"2024-03-11","kind":"exercise","planned":false,"acquired":true,"shares":2561,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F6","text":"Reflects the second vesting installment of RSUs granted on March 11, 2022."}],"balance_after":11838,"source":{"system":"sec-edgar","filing":"0001171843-24-001305","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184324001305/ownership.xml","form_type":"4"}},{"id":1582378,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":81856,"kind":"person","name":"Nunes Anne","position":1,"cik":"0001982862","reported_name":"Nunes Anne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Operations Officer"}}],"security":"Common Stock","published_at":"2024-03-13T00:02:39.000Z","date":"2024-03-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":968,"price":25.42,"value":24606.56,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Reflects an aggregate of 968 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on March 9, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Reflects the closing price of ANIK common stock on March 8, 2024, the trading day prior to which the vesting of RSUs gave rise to tax withholding obligations."}],"balance_after":9277,"source":{"system":"sec-edgar","filing":"0001171843-24-001305","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184324001305/ownership.xml","form_type":"4"}},{"id":1582377,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":81856,"kind":"person","name":"Nunes Anne","position":1,"cik":"0001982862","reported_name":"Nunes Anne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Operations Officer"}}],"security":"Common Stock","published_at":"2024-03-13T00:02:39.000Z","date":"2024-03-11","kind":"exercise","planned":false,"acquired":true,"shares":3295,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the first vesting installment of RSUs granted on March 9, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects the corrected Amount of Shares Beneficially Owned under Table I, Column 2 as reported in Form 3/A filed by the Reporting Person on January 12, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 414 shares acquired under the Anika Therapeutics, Inc. Employee Stock Purchase Plan on November 14, 2023."}],"balance_after":10245,"source":{"system":"sec-edgar","filing":"0001171843-24-001305","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184324001305/ownership.xml","form_type":"4"}},{"id":1768933,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":81856,"kind":"person","name":"Nunes Anne","position":1,"cik":"0001982862","reported_name":"Nunes Anne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Operations Officer"}}],"security":"Restricted Stock Unit","published_at":"2023-10-03T20:31:56.000Z","date":"2023-10-01","kind":"exercise","planned":false,"acquired":false,"shares":2491,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning October 1, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning October 1, 2022."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":2491},"source":{"system":"sec-edgar","filing":"0001171843-23-006018","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184323006018/ownership.xml","form_type":"4"}},{"id":1768932,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":81856,"kind":"person","name":"Nunes Anne","position":1,"cik":"0001982862","reported_name":"Nunes Anne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Operations Officer"}}],"security":"Common Stock","published_at":"2023-10-03T20:31:56.000Z","date":"2023-10-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":732,"price":18.63,"value":13637.16,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Reflects an aggregate of 732 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on October 1, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects the closing price of ANIK common stock on September 29, 2023, the trading day on which the vesting of RSUs gave rise to tax withholding obligations."}],"balance_after":5052,"source":{"system":"sec-edgar","filing":"0001171843-23-006018","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184323006018/ownership.xml","form_type":"4"}},{"id":1768931,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":81856,"kind":"person","name":"Nunes Anne","position":1,"cik":"0001982862","reported_name":"Nunes Anne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Operations Officer"}}],"security":"Common Stock","published_at":"2023-10-03T20:31:56.000Z","date":"2023-10-01","kind":"exercise","planned":false,"acquired":true,"shares":2491,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the second vesting installment of Restricted Stock Units (RSUs) granted on October 1, 2021."}],"balance_after":5784,"source":{"system":"sec-edgar","filing":"0001171843-23-006018","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184323006018/ownership.xml","form_type":"4"}}]}